Elicio Therapeutics (ELTX) Live Share Price, Invest From India

Elicio Therapeutics Stock Performance

as on November 3, 2026 at 2:15 pm IST

Day's Low
Day's High
$1.53
Day's Price Range
$1.80
$1.59
3.77%
Downside
13.21%
Upside
52 Week's Low
52 Week's High
$1.44
52-Week Price Range
$16.00
$1.59
9.43%
Downside
906.29%
Upside

Elicio Therapeutics share price movements today

Previous Close: $1.68
Open: $1.74
Volume: 361.8K
Market Cap: $45.5M
Day's Low - High: $1.53 - $1.80
52 Week Low - High: $1.44 - $16.00

Elicio Therapeutics Historical Returns

1 Month Return: -17.19 %
3 Month Return: -44.41 %
1 Year Return: -82.81 %
3 Year Return: -75.58 %
5 Year Return: 0 %

Elicio Therapeutics Stock Fundamentals & Key Indicators

Check Elicio Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$45.5M

EPS (TTM)

-2.13

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.79

Industry PE ratio

-3.13

PEG Ratio

-0.01

EBITDA

-40.2M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-1266.43%

Elicio Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Elicio Therapeutics with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Elicio Therapeutics	Buy	$45.5M	NA	-0.79	0.00%	0.00%
Moderna	Neutral	$88.5B	-36.16%	-27.78	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$141.7B	192.56%	32.27	86.04%	0.00%
Regeneron	Buy	$95.5B	47.41%	19.76	85.77%	0.40%

Stock Returns calculator for Elicio Therapeutics Stock including INR - Dollar returns

The Elicio Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Elicio Therapeutics investment value today

Current value as on today

₹18,386

Returns

-₹81,614

(-81.61%)

Returns from Elicio Therapeutics Stock

-₹82,811 (-82.81%)

Dollar Impact

₹1,197 (+1.2%)

Analyst Recommendation on Elicio Therapeutics Stock

Based on 3 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 3 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for Elicio Therapeutics. Average target price of $13.67

Elicio Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Elicio Therapeutics.

What analysts predicted

88.37%UPSIDE

Target Price

$13.67

Current Price

$1.59

Analyzed by

3 Analysts

High

$23

Target

$13.67

Low

Elicio Therapeutics target price $13.67, a slight upside of 88.37% compared to current price of $1.59. According to 3 analysts rating.

Indian Investors' Interest in Elicio Therapeutics Stock

Search interest for Elicio Therapeutics Stock has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.

Time period: October 4, 2026 to November 3, 2026

Change:-63% versus previous 30 day period

Elicio Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	-	-	-	0	-
Operating Income	-9	-10	-10	-10	-10	-10	-8	-8	-10	-10
EBITDA	-8	-11	-6	-18	-10	-10	-9	-7	-11	-12
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-8	-11	-7	-18	-11	-10	-10	-7	-11	-8
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-8	-11	-7	-18	-11	-10	-10	-7	-11	-8
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Elicio Therapeutics Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Mar 2025	Dec 2025
Total Revenue	4	1	2	28	-	-	-	-
Gross Profit	3	0	1	27	-1	-1	-1	-1
Operating Income	-14	-38	-55	-39	-23	-35	-44	-37
EBITDA	-14	-40	-70	-52	-23	-32	-50	-37
Interest Expense	-	-	8	0	3	1	0	1
Depreciation	0	0	0	0	1	1	1	1
Income Before Tax	-20	-40	-80	-54	-28	-35	-51	-39
Income Tax Expense	-	-	-	-	-	-	-	-
Net Income	-20	-40	-80	-26	-28	-35	-51	-39
Net Profit Margin	90.57%	23.60%	36.88%	95.64%	0.00%	0.00%	0.00%	0.00%

Elicio Therapeutics Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-8	-11	-7	-18	-11	-10	-10	-7	-11	-8
Operating Cash Flow	-9	-12	-8	-7	-10	-8	-11	-6	-11	-8
Investing Cash Flow	-	0	0	-	-	-	-	0	-	-
Financing Cash Flow	7	11	0	30	10	11	9	4	8	16
Change in Cash	-2	-1	-8	23	0	3	-1	-2	-3	8

Elicio Therapeutics Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Mar 2025	Dec 2025
Net Income	-20	-40	-80	-26	-28	-35	-51	-39
Operating Cash Flow	-8	-24	-22	-23	-22	-32	-37	-36
Investing Cash Flow	-	0	0	0	0	0	0	0
Financing Cash Flow	31	4	52	19	21	38	42	36
Change in Cash	23	-19	29	-5	-80	5	5	0

Global Institutional Holdings in Elicio Therapeutics

Check out the Institutions with significant holdings in Elicio Therapeutics.

Funds	Holdings
Yekaterina Chudnovsky	19.99%
BlackRock, Inc.	2.83%
Vanguard	2.46%
VANGUARD INDEX FUNDS	2.06%
iShares	1.79%

See all

Insights on Elicio Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 184.8% return, outperforming this stock by 260.4%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 786.5% return, outperforming this stock by 869.3%
NEGATIVE IMPACT
Price Dip
In the last 7 days, ELTX stock has moved down by -13.1%

About Elicio Therapeutics

Elicio Therapeutics, Inc. is a clinical-stage biotechnology firm dedicated to creating a diverse array of innovative immunotherapies for the treatment of various cancers and other diseases. The company's primary experimental drug, ELI-002, is an AMP therapeutic vaccine specifically formulated to target KRAS-driven cancers. Its development portfolio also encompasses ELI-004, an AMP-modified CpG adjuvant that forms part of ELI-002; ELI-007, a lymph node-targeted AMP-peptide vaccine addressing mutant BRAF-driven cancers; and ELI-008, a multivalent lymph node-targeted AMP-peptide vaccine for cancers expressing mutant TP53. Furthermore, Elicio is advancing ELI-005, a vaccine candidate for preventing COVID-19, and ELI-011 for hematological malignancies. Another program, ELI-012, is an mKRAS TCR T cell AMP-lifier designed for combined use with mKRAS-targeted TCR T cell therapy against mKRAS-driven cancers. The company's operations are headquartered in Boston, Massachusetts.

Organisation	Elicio Therapeutics
Headquarters	451 D Street, Boston, MA, 02210, US
Industry	Biotechnology
CEO	Robert T. Connelly

Key Management of Elicio Therapeutics

Name	Title
Dr. Preetam Shah M.B.A., Ph.D.	Chief Strategy & Financial Officer and Treasurer
Dr. Christopher M. Haqq M.D., Ph.D.	Executive VP, Head of Research & Development and Chief Medical Officer
Mr. Marc J. Wolfgang M.S.	Chief Technology Officer
Dr. Peter DeMuth Ph.D.	Chief Scientific Officer
Ms. Joy Seymour	Senior VP & Head of Regulatory Affairs
Mr. Robert T. Connelly	CEO, President & Director
Dr. Allen Richard Nissenson F.A.S.N., FACP, M.D.	Founder & Independent Director
Dr. Darrell J. Irvine Ph.D.	Co-Founder, Consultant, Board Observer & Chairman of Scientific Advisory Board
Ms. Megan C. Filoon	General Counsel, Secretary & Compliance Officer
Ms. Esther Welkowsky	Senior Vice President of Clinical Development

FAQs

What is Elicio Therapeutics share price today?

Elicio Therapeutics share price today is $1.59 as on November 3, 2026 at 8:45 am IST at the close of the market. Elicio Therapeutics share today touched a day high of $1.80 and a low of $1.53.

What is the 52 week high and 52 week low for Elicio Therapeutics share?

Elicio Therapeutics share touched a 52 week high of $16.00 on June 10, 2026 and a 52 week low of $1.44 on October 19, 2026. Elicio Therapeutics stock price today i.e. November 3, 2026 at 8:45 am IST is closed at $1.59,which is 90.06% down from its 52 week high and 10.42% up from its 52 week low.

What is Elicio Therapeutics's market capitalisation today?

Elicio Therapeutics market capitalisation is $0.00T as on November 3, 2026 at 8:45 am IST.

How to invest in Elicio Therapeutics Stock (ELTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Elicio Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Elicio Therapeutics Stock (ELTX) from India?

Indian investors can start investing in Elicio Therapeutics (ELTX) shares with as little as ₹94.9000015258789 or $1 (as of November 3, 2026 at 3:57 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.00 in Elicio Therapeutics stock (as per the Rupee-Dollar exchange rate as on November 3, 2026 at 3:57 pm IST). Based on Elicio Therapeutics share’s latest price of $1.59 as on November 3, 2026 at 8:45 am IST, you will get 6.2893 shares of Elicio Therapeutics. Learn more about fractional shares .